Kambo

Ayahuasca is a traditional Amazonian plant brew combining the Banisteriopsis caapi vine (containing MAO inhibitors) with Psychotria viridis leaves (containing DMT). The MAO inhibitors allow the orally inactive DMT to become psychoactive, creating a profound 4-6 hour visionary experience. Indigenous peoples of the Amazon have used ayahuasca for thousands of years in shamanic healing ceremonies for physical ailments, emotional distress, spiritual guidance, and treating addiction. Modern research shows ayahuasca promotes neuroplasticity through sigma-1 receptor activation at mitochondria-associated membranes, reducing inflammation, oxidative stress, and cellular stress responses. Clinical studies demonstrate rapid antidepressant effects, with single doses reducing HAM-D and MADRS scores significantly for up to 21 days. The brew's beta-carboline alkaloids (harmine, harmaline, tetrahydroharmine) contribute additional anthelmintic, antimicrobial, vasorelaxant, and neuroprotective properties. Ayahuasca shows particular promise for substance dependence, acting on mesolimbic dopaminergic and serotonergic pathways to break addiction cues and attenuate withdrawal symptoms. The experience typically involves purging (vomiting, diarrhea), which is considered part of the healing process. Emerging research suggests potential for neurodegenerative conditions like Parkinson's, Alzheimer's, and ALS.

Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga shrub, native to Central West Africa. The Bwiti tradition of Gabon has used iboga in spiritual initiation ceremonies for centuries. Ibogaine is unique among psychedelics for its remarkable ability to interrupt addiction, particularly to opioids, with a single treatment often eliminating acute withdrawal symptoms for weeks and reducing cravings for months. The mechanism involves resetting multiple neurotransmitter systems, including dopamine, serotonin, and opioid receptors, while promoting neuroplasticity and allowing psychological processing of addiction's root causes. A typical ibogaine experience lasts 8-12 hours and involves a waking dream state with intense introspection, life review, and often vivid visions addressing the psychological origins of addiction. Studies show up to 88% reduction in PTSD symptoms post-treatment. However, ibogaine carries significant cardiac risks, including QT interval prolongation and potential fatal arrhythmias, necessitating rigorous medical screening and monitoring. Treatment centers in Mexico (Tijuana, Cancun, Playa del Carmen) and Portugal provide medically supervised protocols with cardiac monitoring, pre-treatment screening, and integration support. Texas approved $50 million in 2025 for clinical trials investigating ibogaine for addiction and brain trauma, signaling growing legitimacy.

Bufo alvarius (now Incilius alvarius), the Sonoran Desert toad, produces venom containing high concentrations of 5-MeO-DMT, one of the most potent psychedelics known. Despite widespread belief in traditional indigenous use, there is no verified evidence of ceremonial toad venom consumption by indigenous peoples. The Yaqui of the Sonoran Desert considered the toad culturally significant in art and stories but explicitly deny historical ingestion of its venom as psychoactive. Archaeological evidence suggests Mesoamerican awareness of psychoactive toads, but not confirmed ceremonial use. Modern "Bufo ceremonies" emerged around 2015 as neo-shamanic practices, often held at retreats in Tulum, Riviera Maya, Sonora, Oaxaca (Mexico), and Peru's Sacred Valley. The dried venom is vaporized and smoked, producing an extremely intense 15-45 minute experience of ego dissolution, unity consciousness, white light, and often profound healing or trauma release. The toad naturally secretes venom from glands when threatened; this is collected, dried, and stored. Rising global demand for Bufo ceremonies has created serious conservation concerns, with wild toad populations under pressure from over-harvesting. Synthetic 5-MeO-DMT offers an identical experience without harming toads and is increasingly preferred by ethical practitioners. The experience is considered one of the most powerful and potentially transformative in psychedelic medicine, but also carries risks of overwhelming psychological intensity.